Association Between Post-Partum Anaemia and Depressive Symptoms at Two Months After Vaginal Delivery: A Secondary Analysis of the TRAAP Trial
- PMID: 40653995
- PMCID: PMC12411663
- DOI: 10.1111/1471-0528.18289
Association Between Post-Partum Anaemia and Depressive Symptoms at Two Months After Vaginal Delivery: A Secondary Analysis of the TRAAP Trial
Abstract
Objective: To assess the association between maternal haemoglobinaemia in the immediate post-partum period and PPD symptoms 2 months after vaginal delivery.
Design: Ancillary cohort study of the TRAAP trial, a multicentre trial.
Setting: In France, 2015-2016.
Population: Women with a singleton pregnancy and vaginal delivery ≥ 35 weeks. We excluded women with known psychiatric conditions and those who were non-respondent to the Edinburgh Post-partum Depression Scale (EPDS) questionnaire.
Methods: The exposure was immediate post-partum haemoglobinemia (systematically collected in TRAAP trial) as a continuous variable.
Main outcome: PPD symptoms at 2 months post-partum, defined as an EPDS score ≥ 11. We also differentiated two levels of PPD symptom severity: moderate (11 ≤ EPDS < 13) and severe (EPDS ≥ 13) depressive symptoms.
Results: Amongst the 2672 women included, 1115 (43.6%) had post-partum anaemia (haemoglobin < 11 g/dL) in the immediate post-partum and 369 (13.8%) had PPD symptoms at 2 months. The relation between haemoglobin and PPD symptoms was linear. In the multivariable analysis, each 1 g/dL increase in haemoglobin level was associated with a 9% decrease in the risk of post-partum depression symptoms (adjusted Relative Risk 0.91; 95% CI 0.82-0.997). Post-partum haemoglobin was specifically associated with moderate depressive symptoms (adjusted Relative Risk 0.84; 95% CI, 0.72-0.98) but not with severe depressive symptoms (aRR 0.95; 95% CI, 0.84-1.07).
Conclusions: In women with vaginal delivery, each 1 g/dL increase in haemoglobin level was associated with a 9% decrease in the risk of post-partum depression symptoms.
Keywords: maternal mental health; post‐partum anaemia; post‐partum depression; post‐partum haemoglobin level; vaginal delivery.
© 2025 The Author(s). BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
Conflict of interest statement
L.S. performed consultancy work and was a lecturer for Ferring Laboratories, GlaxoSmithKline, and Bayer. Moreover, L.S. has been a lecturer for Norgine for 3 years. M.P.B. has received honoraria from Novonordisk and 3 M Health Care. The other authors report no conflicts of interest.
Figures
References
-
- Froeliger A., Deneux‐Tharaux C., Loussert L., et al., “Prevalence and Risk Factors for Postpartum Depression 2 Months After a Vaginal Delivery: A Prospective Multicenter Study,” American Journal of Obstetrics and Gynecology 230, no. 3 (2023): S0002‐9378(23)00596–3. - PubMed
-
- Cantwell R., “Mental Disorder in Pregnancy and the Early Postpartum,” Anaesthesia 76, no. Suppl 4 (2021): 76–83. - PubMed
-
- Saucedo M., Deneux‐Tharaux C., and pour le comité national d'experts sur les mort maternelles (CNEMM) , “Maternal Mortality in France, 2016‐2018, Frequency, Causes and Women's Profile,” Gynecology Obstetrics & Fertility Senology 52, no. 4 (2024): 185–200. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
